486
Participants
Start Date
January 31, 2013
Primary Completion Date
March 31, 2015
Study Completion Date
March 31, 2015
Ceftazidime-avibactam
Ceftazidime-Avibactam powder for concentrate for solution for infusion 2000 mg/500 mg
metronidazole
Metronidazole 500mg/100ml solution for infusion
Meropenem
Meropenem powder for solution for infusion 1000mg
Research Site, Baotou
Research Site, Beijing
Research Site, Changsha
Research Site, Chengdu
Research Site, Chongqing
Research Site, Fuzhou
Research Site, Guangzhou
Research Site, Guilin
Research Site, Haikou
Research Site, Hebei
Research Site, Jiangyin
Research Site, Liaocheng
Research Site, Nanchang
Research Site, Shanghai
Research Site, Tianjin
Research Site, Ürümqi
Research Site, Wenzhou
Research Site, Wuxi
Research Site, Xi'an
Research Site, Ansan-si
Research Site, Anyang-si
Research Site, Busan
Research Site, Cheongju-si
Research Site, Daejeon
Research Site, Gwangju
Research Site, Jinju
Research Site, Seoul
Research Site, Wŏnju
Research Site, Hanoi
Research Site, Hochiminh
Lead Sponsor
Pfizer
INDUSTRY